William Blair Downgrades Amgen to “Market Perform” (AMGN)

Biotech giant Amgen, Inc. (AMGN) was downgraded by analysts at William Blair on Tuesday, as the company may be in store for a transitional year in 2013.

The analysts downgraded AMGN from “Outperform” to “Market Perform.”

Amgen shares were down slightly during morning trading on Tuesday. The stock is up about +26% over the past year.

The Bottom Line
Shares of Amgen, Inc. (AMGN) have a dividend yield of 2.23% based on Tuesday’s intraday trading price of $84.43 and the company’s annualized dividend payout of $1.88 per share.

Amgen, Inc. (AMGN)is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here